123 related articles for article (PubMed ID: 4034625)
1. Failure of chronic haloperidol to affect prolactin secretion due to acute haloperidol administration.
Parati EA; Parenti M; Locatelli V; Penalva A; Tamminga C; Müller EE
Pharmacol Res Commun; 1985 May; 17(5):407-15. PubMed ID: 4034625
[TBL] [Abstract][Full Text] [Related]
2. Chronic domperidone fails to increase striatal spiperone binding sites despite hyperprolactinemia: comparison with chronic haloperidol.
Morgan DG; Sinha YN; Finch CE
Neuroendocrinology; 1984 May; 38(5):407-10. PubMed ID: 6728123
[TBL] [Abstract][Full Text] [Related]
3. Effects of repeated tiapride administration on anterior pituitary dopamine receptors and prolactin release in the rat.
Apud JA; Masotto C; Monopoli A; Ongini E; Rovescalli AC; Racagni G
Pharmacol Res Commun; 1987 Feb; 19(2):119-29. PubMed ID: 3588649
[TBL] [Abstract][Full Text] [Related]
4. Effect of estradiol and haloperidol on hypophysectomized rat brain dopamine receptors.
Di Paolo T; Daigle M; Labrie F
Psychoneuroendocrinology; 1984; 9(4):399-404. PubMed ID: 6514934
[TBL] [Abstract][Full Text] [Related]
5. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.
Wilmot CA; Szczepanik AM
Brain Res; 1989 May; 487(2):288-98. PubMed ID: 2525063
[TBL] [Abstract][Full Text] [Related]
6. Regulation and molecular characterization of dopamine D2 receptors in a prolactin-secreting 7315a anterior pituitary tumor.
Lew JY; Zawadzka H; Feigenblum D; Tang D; Filer D; Benedetto P; Goldstein M
Eur J Pharmacol; 1990 Jun; 188(6):329-34. PubMed ID: 1695574
[TBL] [Abstract][Full Text] [Related]
7. Differential influence of haloperidol and sulpiride on dopamine receptors and peptide mRNA levels in the rat striatum and pituitary.
Jaber M; Tison F; Fournier MC; Bloch B
Brain Res Mol Brain Res; 1994 Apr; 23(1-2):14-20. PubMed ID: 7518029
[TBL] [Abstract][Full Text] [Related]
8. Chronic haloperidol affects striatal D2-dopamine receptor reappearance after irreversible receptor blockade.
Pich EM; Benfenati F; Farabegoli C; Fuxe K; Meller E; Aronsson M; Goldstein M; Agnati LF
Brain Res; 1987 Dec; 435(1-2):147-52. PubMed ID: 2962698
[TBL] [Abstract][Full Text] [Related]
9. Chronic haloperidol does not alter agonist affinity for dopamine receptors in vitro.
Meller E; Bohmaker K; Goldstein M; Schweitzer JW; Friedhoff AJ
Eur J Pharmacol; 1985 Mar; 109(3):389-94. PubMed ID: 3157587
[TBL] [Abstract][Full Text] [Related]
10. Differential effects on D2 dopamine receptor and prolactin gene expression by haloperidol and aripiprazole in the rat pituitary.
Inoue A; Seto M; Sugita S; Hide I; Hirose T; Koga N; Kikuchi T; Nakata Y
Brain Res Mol Brain Res; 1998 Apr; 55(2):285-92. PubMed ID: 9582438
[TBL] [Abstract][Full Text] [Related]
11. Hyperprolactinaemia does not alter specific striatal 3H-spiperone binding in the rat.
Simpson MD; Jenner P; Marsden CD
Biochem Pharmacol; 1986 Oct; 35(19):3203-8. PubMed ID: 3768017
[TBL] [Abstract][Full Text] [Related]
12. Hypophysectomy may non-selectively alter pharmacokinetic parameters to enhance the ability of haloperidol to increase striatal dopamine receptor density in the rat.
Simpson MD; Jenner P; Marsden CD
Biochem Pharmacol; 1986 Oct; 35(20):3501-6. PubMed ID: 3768037
[TBL] [Abstract][Full Text] [Related]
13. Genotypic influences on pituitary responsiveness to haloperidol in mice.
Morgan DG; Randall JS; Telford NA; Gordon MN; Sinha YN; Finch CE; Randall PK
Psychoneuroendocrinology; 1987; 12(3):211-8. PubMed ID: 3615750
[TBL] [Abstract][Full Text] [Related]
14. Factors contributing to the up regulation of dopaminergic receptors by chronic haloperidol.
Schweitzer JW; Schwartz R; Friedhoff AJ
Res Commun Chem Pathol Pharmacol; 1982 Oct; 38(1):21-30. PubMed ID: 7146618
[TBL] [Abstract][Full Text] [Related]
15. Effect of haloperidol and apomorphine treatment on dopamine receptors in pituitary and striatum.
Friend WC; Brown GM; Jawahir G; Lee T; Seeman P
Am J Psychiatry; 1978 Jul; 135(7):839-41. PubMed ID: 665797
[TBL] [Abstract][Full Text] [Related]
16. Absence of [3H]SCH 23390 specific binding sites in anterior pituitary: dissociation from effects on prolactin secretion.
Rovescalli AC; Brunello N; Monopoli A; Ongini E; Racagni G
Eur J Pharmacol; 1987 Mar; 135(2):129-36. PubMed ID: 3556197
[TBL] [Abstract][Full Text] [Related]
17. Differential modulation of dopamine D2 receptors by chronic haloperidol, nitrendipine, and pimozide.
Tecott LH; Kwong LL; Uhr S; Peroutka SJ
Biol Psychiatry; 1986 Oct; 21(12):1114-22. PubMed ID: 2428411
[TBL] [Abstract][Full Text] [Related]
18. Interaction of SCH 23390, a D-1-selective antagonist, with the anterior pituitary D-2 receptors and prolactin secretion in the rat.
Apud JA; Masotto C; Ongini E; Racagni G
Eur J Pharmacol; 1985 Jun; 112(2):187-93. PubMed ID: 2863153
[TBL] [Abstract][Full Text] [Related]
19. Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats.
Rupniak NM; Kilpatrick G; Hall MD; Jenner P; Marsden CD
Psychopharmacology (Berl); 1984; 84(4):512-9. PubMed ID: 6441952
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of prolactin-secreting effect produced by repeated administration of haloperidol in the avoidance situation and dopamine neurons in rats.
Hayashi T; Kifune A; Tadokoro S
Jpn J Pharmacol; 1988 Nov; 48(3):387-90. PubMed ID: 3221537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
